NDC 0555-0589
Didanosine
Didanosine
Didanosine is a Oral Capsule, Delayed Release Pellets in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa,. The primary component is Didanosine.
| Product ID | 0555-0589_26a65fcc-62e2-4807-aa52-5bd5cbd6389e |
| NDC | 0555-0589 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Didanosine |
| Generic Name | Didanosine |
| Dosage Form | Capsule, Delayed Release Pellets |
| Route of Administration | ORAL |
| Marketing Start Date | 2004-12-15 |
| Marketing End Date | 2019-03-31 |
| Marketing Category | ANDA / |
| Application Number | ANDA077167 |
| Labeler Name | Teva Pharmaceuticals USA, |
| Substance Name | DIDANOSINE |
| Active Ingredient Strength | 250 mg/1 |
| Pharm Classes | Human Immunodef |
| NDC Exclude Flag | N |